Date: Tuesday 30 October
Time: 730 – 830
Venue: City Room 1
Registration: Included in EPSM registration
Over 1000 clinics worldwide rely on Mobius QA products. This acquisition allows Varian to both expand its QA portfolio and use the established Mobius QA solutions to improve treatment outcomes on a global scale. Varian will continue to develop the Mobius QA product line as part of its strategy to transform from a radiation therapy company to a broader cancer care company.
The new Varian QA portfolio provides customers with QA that can be deeply integrated into clinical workflows and develop at the same pace as new treatment techniques.
The Mobius QA solutions include the Mobius3D web-based patient QA platform and the DoseLab machine QA system.
This breakfast sesssion is sponsored by: